In-vivo range verification analysis with in-beam PET data for patients treated with proton therapy at CNAO
Open Access
- 26 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 929949
Abstract
Morphological changes that may arise through a treatment course are probably one of the most significant sources of range uncertainty in proton therapy. Non-invasive in-vivo treatment monitoring is useful to increase treatment quality. The INSIDE in-beam Positron Emission Tomography (PET) scanner performs in-vivo range monitoring in proton and carbon therapy treatments at the National Center of Oncological Hadrontherapy (CNAO). It is currently in a clinical trial (ID: NCT03662373) and has acquired in-beam PET data during the treatment of various patients. In this work we analyze the in-beam PET (IB-PET) data of eight patients treated with proton therapy at CNAO. The goal of the analysis is twofold. First, we assess the level of experimental fluctuations in inter-fractional range differences (sensitivity) of the INSIDE PET system by studying patients without morphological changes. Second, we use the obtained results to see whether we can observe anomalously large range variations in patients where morphological changes have occurred. The sensitivity of the INSIDE IB-PET scanner was quantified as the standard deviation of the range difference distributions observed for six patients that did not show morphological changes. Inter-fractional range variations with respect to a reference distribution were estimated using the Most-Likely-Shift (MLS) method. To establish the efficacy of this method, we made a comparison with the Beam’s Eye View (BEV) method. For patients showing no morphological changes in the control CT the average range variation standard deviation was found to be 2.5 mm with the MLS method and 2.3 mm with the BEV method. On the other hand, for patients where some small anatomical changes occurred, we found larger standard deviation values. In these patients we evaluated where anomalous range differences were found and compared them with the CT. We found that the identified regions were mostly in agreement with the morphological changes seen in the CT scan.Keywords
This publication has 33 references indexed in Scilit:
- Automation and uncertainty analysis of a method forin-vivorange verification in particle therapyPhysics in Medicine & Biology, 2014
- An in-beam PET system for monitoring ion-beam therapy: test on phantoms using clinical 62 MeV protonsJournal of Instrumentation, 2014
- Dose Uncertainties in IMPT for Oropharyngeal Cancer in the Presence of Anatomical, Range, and Setup ErrorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- In vivoproton range verification: a reviewPhysics in Medicine & Biology, 2013
- Charged particle therapy—optimization, challenges and future directionsNature Reviews Clinical Oncology, 2013
- TOFPET ASIC for PET applicationsJournal of Instrumentation, 2013
- The status of CNAOThe European Physical Journal Plus, 2011
- The Development and Clinical Use of a Beam ON-LINE PET System Mounted on a Rotating Gantry Port in Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Quantitative assessment of the physical potential of proton beam range verification with PET/CTPhysics in Medicine & Biology, 2008
- On the detector arrangement for in-beam PET for hadron therapy monitoringPhysics in Medicine & Biology, 2006